Loading...
XSHE
002219
Market cap1.01bUSD
Jul 10, Last price  
1.98CNY
1D
10.00%
1Q
-17.15%
Jan 2017
-83.47%
IPO
0.24%
Name

New Journey Health Technology Group Co Ltd

Chart & Performance

D1W1MN
XSHE:002219 chart
P/E
220.88
P/S
2.24
EPS
0.01
Div Yield, %
Shrs. gr., 5y
12.03%
Rev. gr., 5y
0.24%
Revenues
3.05b
-19.64%
284,972,508285,116,048299,331,669307,244,763336,964,447564,725,359685,657,6501,181,728,2222,175,221,1863,399,304,2053,838,392,1963,684,467,7212,805,895,4943,016,070,7333,016,070,7323,152,734,8803,160,965,3963,914,292,0173,799,010,3133,052,738,508
Net income
31m
-73.04%
44,511,22547,805,40765,961,42971,345,72673,672,380169,827,051257,332,865323,626,323403,631,495202,809,270-1,417,817,716-2,519,543,753-52,243,8210-371,431,511156,121,502156,121,50428,971,943114,765,52930,942,846
CFO
294m
-33.00%
13,549,75231,880,72122,369,35632,627,52664,425,81594,803,99382,705,472158,400,972193,353,694219,021,90300522,565,203549,512,401283,796,318277,294,763268,039,414290,977,690438,505,853293,786,255
Dividend
Feb 28, 20140.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

This company maintains a diverse business portfolio, encompassing the provision of medical services, pharmaceutical manufacturing, and the distribution of daily chemical and wellness products. Its pharmaceutical production includes various dosage forms such as tablets, syrups, capsules, mixtures, and pills. The enterprise was established on September 30, 2001, with its primary office situated in Beijing, China.
IPO date
Mar 06, 2008
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT